Skip to main content
Signal8

Corning Luke

SEC insider (Form 3/4/5 filer). CIK 0001836654. Director at Poseida Therapeutics, Inc. (PSTX). 5 reported Form 4/5 transactions since Sep 2024; latest on Jan 8, 2025. Located in SAN DIEGO, CA.

Companies Corning Luke has filed insider reports for

  • Poseida Therapeutics, Inc. (PSTX): Director
Corning Luke profile photo

Corning Luke

CIK: 0001836654

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)5 (100.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Poseida Therapeutics, Inc. logo
PSTX

Poseida Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (5 total)

  • Poseida Therapeutics, Inc. logo
    PSTX

    Poseida Therapeutics, Inc.

    Jan 8, 2025
    Tender Offer
    Direct
    59K shares-
  • Poseida Therapeutics, Inc. logo
    PSTX

    Poseida Therapeutics, Inc.

    Jan 8, 2025
    Disposition

    Stock Option (Right to Buy)

    Direct
    45.8K shares-
  • Poseida Therapeutics, Inc. logo
    PSTX

    Poseida Therapeutics, Inc.

    Jan 8, 2025
    Disposition

    Stock Option (Right to Buy)

    Direct
    28.5K shares-
  • Poseida Therapeutics, Inc. logo
    PSTX

    Poseida Therapeutics, Inc.

    Jan 8, 2025
    Disposition

    Stock Option (Right to Buy)

    Direct
    27.4K shares-
  • Poseida Therapeutics, Inc. logo
    PSTX

    Poseida Therapeutics, Inc.

    Jan 8, 2025
    Disposition

    Stock Option (Right to Buy)

    Direct
    27.4K shares-

1-5 of 5